A culturally adapted lifestyle intervention addressing a Middle Eastern immigrant population at risk of diabetes, the MEDIM (impact of Migration and Ethnicity on Diabetes In Malmö): Study protocol for a randomized controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  Saha, Sanjib ^a   Leijon, Matti ^a   Gerdtham, Ulf ^a   Sundquist, Kristina ^a,b   Sundquist, Jan ^a,b   Arvidsson, Daniel ^a   Bennet, Louise ^a  

^a LUND UNIVERSITY   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CULTURAL ANTHROPOLOGY; DIET; ENDURANCE TRAINING; EVIDENCE BASED PRACTICE; FEEDING BEHAVIOR; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIGH RISK POPULATION; HUMAN; IMMIGRANT; INSULIN SENSITIVITY; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MIDDLE EAST; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT COUNSELING; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SIMULATION; WEIGHT REDUCTION;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ARABS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; CULTURAL CHARACTERISTICS; DIABETES MELLITUS, TYPE 2; DIET; EMIGRANTS AND IMMIGRANTS; EMIGRATION AND IMMIGRATION; EXERCISE; FOOD HABITS; HEALTH CARE COSTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTENTION TO TREAT ANALYSIS; IRAQ; LIFE STYLE; MALE; MIDDLE AGED; MODELS, ECONOMIC; RESEARCH DESIGN; RISK FACTORS; RISK REDUCTION BEHAVIOR; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84883296418     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-279     Document Type: Article

References (66)

1. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234. 10.1056/NEJM199807233390404, 9673301.
2. Writing C, Unwin N, Shaw J, Zimmet P, Alberti KGMM. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002, 19:708-723.
3. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: A global public health problem and a new definition. J Atheroscler Thromb 2005, 12:295-300. 10.5551/jat.12.295, 16394610.
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care 2004, 27:1047-1053. 10.2337/diacare.27.5.1047, 15111519.
5. Wandell PE, Johansson SE, Gafvels C, Hellenius ML, de Faire U, Sundquist J. Estimation of diabetes prevalence among immigrants from the Middle East in Sweden by using three different data sources. Diabetes Metab 2008, 34:328-333. 10.1016/j.diabet.2008.01.012, 18539497.
6. Wandell PE, Wajngot A, de Faire U, Hellenius ML. Increased prevalence of diabetes among immigrants from non-European countries in 60-year-old men and women in Sweden. Diabetes Metab 2007, 33:30-36. 10.1016/j.diabet.2006.07.001, 17258927.
7. Bennet L, Johansson S-E, Agardh C-D, Groop L, Sundquist J, Rastam L, Sundquist K. High prevalence of type 2 diabetes in Iraqi and Swedish residents in a deprived Swedish neighbourhood - a population based study. BMC Publ Health 2011, 11:303.
8. Glans F, Elgzyri T, Shaat N, Lindholm E, Apelqvist J, Groop L. Immigrants from the Middle-East have a different form of type 2 diabetes compared with Swedish patients. Diabet Med 2008, 25:303-307. 10.1111/j.1464-5491.2007.02366.x, 18307458.
9. Dela F, von Linstow ME, Mikines KJ, Galbo H. Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 2004, 287:E1024-E1031. 10.1152/ajpendo.00056.2004, 15251867.
10. Slentz CA, Tanner CJ, Bateman LA, Durheim MT, Huffman KM, Houmard JA, Kraus WE. Effects of exercise training intensity on pancreatic β-cell function. Diabetes Care 2009, 32:1807-1811. 10.2337/dc09-0032, 2752909, 19592624.
11. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403. 1370926, 11832527.
12. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350. 10.1056/NEJM200105033441801, 11333990.
13. Group TDPPR. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care 2003, 26:36-47. 1402339, 12502656.
14. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008, 371:1783-1789. 10.1016/S0140-6736(08)60766-7, 18502303.
15. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2008, 368:1673-1679.
16. Diabetes Prevention Program Research G 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009, 374:1677-1686. 10.1016/S0140-6736(09)61457-4, 3135022, 19878986, Diabetes Prevention Program Research G.
17. Jaber LA, Pinelli NR, Brown MB, Funnell MM, Anderson R, Hammad A, Herman WH. Feasibility of group lifestyle intervention for diabetes prevention in Arab Americans. Diabetes Res Clin Pract 2011, 91:307-315. 10.1016/j.diabres.2010.11.032, 3055934, 21168232.
18. Lirussi F. The global challenge of type 2 diabetes and the strategies for response in ethnic minority groups. Diabetes Metab Res Rev 2010, 26:421-432. 10.1002/dmrr.1105, 20641140.
19. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes 2005, Oxford: Oxford University Press.
20. Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Engelgau MM. Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. Diabetes Care 2007, 30:2874-2879. 10.2337/dc07-0885, 17698614.
21. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003, 26:725-731. 10.2337/diacare.26.3.725, 12610029.
22. Pinelli NR, Herman WH, Brown MB, Jaber LA. Perceived risk and the willingness to enroll in a diabetes prevention lifestyle intervention in Arab-Americans. Diabetes Res Clin Pract 2010, 90:e27-e29. 10.1016/j.diabres.2010.08.010, 2956269, 20833442.
23. Paulweber B, Valensi P, Lindstrom J, Lalic NM, Greaves CJ, McKee M, Kissimova-Skarbek K, Liatis S, Cosson E, Szendroedi J, et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010, 42(1):S3-S36.
24. Lindstrom J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, Handke U, Pajunen P, Puhl S, Polonen A, Rissanen A, et al. Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res 2010, 42(1):S37-S55.
25. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991, 34:891-898. 10.1007/BF00400196, 1778354.
26. Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003, 26:3230-3236. 10.2337/diacare.26.12.3230, 14633807.
27. Kallings LV, Leijon M, Hellénius ML, Ståhle A. Physical activity on prescription in primary health care: a follow-up of physical activity level and quality of life. Scand J Med Sci Sports 2008, 18:154-161.
28. Thorell J, Larson SM. Radioimmunoassay and Related Techniques: Methodology and Clinical Applications 1978, St louis: The CV Mosby Company.
29. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974, 20:470-475.
30. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
31. von Schenck H, Falkensson M, Lundberg B. Evaluation of "HemoCue," a new device for determining hemoglobin. Clin Chem 1986, 32:526-529.
32. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470. 10.2337/diacare.22.9.1462, 10480510.
33. Hanson RL, Pratley RE, Bogardus C, Narayan KMV, Roumain JML, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH, Knowler WC. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemioiogic studies. Am J Epidemiol 2000, 151:190-198. 10.1093/oxfordjournals.aje.a010187, 10645822.
34. Sluiter WJ, Erkelens DW, Reitsma WD, Doorenbos H. Glucose tolerance and insulin release, a mathematical approach: I. Assay of the beta-cell response after oral glucose loading. Diabetes 1976, 25:241-244. 10.2337/diabetes.25.4.241, 773721.
35. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of β-cell function: the hyperbolic correction. Diabetes 2002, 51:S212-S220. 10.2337/diabetes.51.2007.S212, 11815482.
36. van Poppel MNM, Chinapaw MJM, Mokkink LB, van Mechelen W, Terwee CB. Physical activity questionnaires for adults: a systematic review of measurement properties. Sports Med 2010, 40:565-600. doi.org/10.2165/11531930-000000000-00000, 10.2165/11531930-000000000-00000, 20545381.
37. Prince S, Adamo K, Hamel M, Hardt J, Gorber S, Tremblay M. A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review. Int J Behav Nutr Phys Act 2008, 5:56. 10.1186/1479-5868-5-56, 2588639, 18990237.
38. Santos-Lozano A, Marin PJ, Torres-Luque G, Ruiz JR, Lucia A, Garatachea N. Technical variability of the GT3X accelerometer. Med Eng Phys 2012, 34:787-790. 10.1016/j.medengphy.2012.02.005, 22417978.
39. Santos-Lozano A, Torres-Luque G, Marin PJ, Ruiz JR, Lucia A, Garatachea N. Intermonitor variability of GT3X accelerometer. Int J Sports Med 2012, 33:994-999.
40. Kozey-Keadle S, Libertine A, Lyden K, Staudenmayer J, Freedson PS. Validation of wearable monitors for assessing sedentary behavior. Med Sci Sports Exerc 2011, 43:1561-1567. 10.1249/MSS.0b013e31820ce174, 21233777.
41. Sasaki JE, John D, Freedson PS. Validation and comparison of ActiGraph activity monitors. J Sci Med Sport 2011, 14:411-416. 10.1016/j.jsams.2011.04.003, 21616714.
42. Wickel EE, Welk GJ. Applying generalizability theory to estimate habitual activity levels. Med Sci Sports Exerc 2010, 42:1528-1534. 10.1249/MSS.0b013e3181d107c4, 20139788.
43. Burr JF, Bredin SS, Faktor MD, Warburton DE. The 6-minute walk test as a predictor of objectively measured aerobic fitness in healthy working-aged adults. Phys Sportsmed 2011, 39:133-139.
44. Oja P, Laukkanen R, Pasanen M, Tyry T, Vuori I. A 2-km walking test for assessing the cardiorespiratory fitness of healthy adults. Int J Sports Med 1991, 12:356-362. 10.1055/s-2007-1024694, 1917218.
45. KOST och NÄRINGSDATA http://www.kostdata.se/, KOST och NÄRINGSDATA.
46. Agardh E, Moradi T, Allebeck P. The contribution of risk factors to the burden of disease in Sweden. A comparison between Swedish and WHO data. Lakartidningen 2008, 105:816-821.
47. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The Alcohol Use Disorders Identification Test Guidelines for Use in Primary Care 2001, Geneva: World Health Organization, Secondth.
48. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011, 20:1727-1736. 10.1007/s11136-011-9903-x, 3220807, 21479777.
49. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
50. Bunevicius A, Peceliuniene J, Mickuviene N, Valius L, Bunevicius R. Screening for depression and anxiety disorders in primary care patients. Depress Anxiety 2007, 24:455-460. 10.1002/da.20274, 17117433.
51. el-Rufaie OE, Absood GH. Retesting the validity of the Arabic version of the Hospital Anxiety and Depression (HAD) scale in primary health care. Soc Psychiatry Psychiatr Epidemiol 1995, 30:26-31. 10.1007/BF00784431, 7892615.
52. DiClemente CC, Prochaska JO. Self-change and therapy change of smoking behavior: a comparison of processes of change in cessation and maintenance. Addict Behav 1982, 7:133-142. 10.1016/0306-4603(82)90038-7, 7102444.
53. Norcross JC, Krebs PM, Prochaska JO. Stages of change. J Clin Psychol 2011, 67:143-154. 10.1002/jclp.20758, 21157930.
54. van Sluijs EM, van Poppel MN, van Mechelen W. Stage-based lifestyle interventions in primary care: are they effective?. Am J Prev Med 2004, 26:330-343.
55. Deci EL, Ryan RM. The" what" and" why" of goal pursuits: human needs and the self-determination of behavior. Psychol Inq 2000, 11:227-268.
56. Teixeira PJ, Carraca EV, Markland D, Silva MN, Ryan RM. Exercise, physical activity, and self-determination theory: a systematic review. Int J Behav Nutr Phys Act 2012, 9:78. 10.1186/1479-5868-9-78, 3441783, 22726453.
57. Levesque CS, Williams GC, Elliot D, Pickering MA, Bodenhamer B, Finley PJ. Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors. Heal Educ Res 2007, 22:691-702.
58. World Health Organization -CHOosing Intervention that are Cost Effective (WHO-CHOICE) http://www.who.int/choice/costs/CER_thresholds/en/index.html.
59. Bala MV, Mauskopf JA, Wood LL. Willingness to pay as a measure of health benefits. Pharmacoeconomics 1999, 15:9-18. 10.2165/00019053-199915010-00002, 10345161.
60. Jacobs N, Drost R, Ament A, Evers S, Claes N. Willingness to pay for a cardiovascular prevention program in highly educated adults: a randomized controlled trial. Int J Technol Assess Health Care 2011, 27:283-289. 10.1017/S0266462311000341, 22004768.
61. Romé T, Persson U, Ekdahl C, Gard G. Willingness to pay for health improvements of physical activity on prescription. Scand J Public Health 2010, 38:151-159. 10.1177/1403494809357099, 20064920.
62. World Health Organization Process of translation and adaptation of instruments. http://www.who.int/substance_abuse/research_tools/translation/en/, World Health Organization.
63. Kalter-Leibovici O, Younis-Zeidan N, Atamna A, Lubin F, Alpert G, Chetrit A, Novikov I, Daoud N, Freedman LS. Lifestyle intervention in obese Arab women: a randomized controlled trial. Arch Intern Med 2010, 170:970-976. 10.1001/archinternmed.2010.103, 20548010.
64. Glick HA. Sample size and power for cost-effectiveness analysis (Part 2): the effect of maximum willingness to pay. Pharmacoeconomics 2011, 29:287-296.
65. Glick HA. Sample size and power for cost-effectiveness analysis (part 1). Pharmacoeconomics 2011, 29:189-198. 10.2165/11585070-000000000-00000, 21309615.
66. Sofian M, Omar-Fauzee UPM, Abd-Latif R. The perspective of Arabic Muslim women toward sport participation. J Asia Pacific Studies 2010, 1:364-377.